Reagent kit for determining the concentration of total cholesterol in serum and plasma (CHOLESTEROL-1-OLVEX) as per TU 9398-042-44276594-2007
Russia·204950·OLVEX DIAGNOSTICS LLC·Registered December 28, 2022·Class 2a- Device Name (English)
- Reagent kit for determining the concentration of total cholesterol in serum and plasma (CHOLESTEROL-1-OLVEX) as per TU 9398-042-44276594-2007
- Device Name (Russian)
- Набор реагентов для определения концентрации общего холестерина в сыворотке и плазме крови (ХОЛЕСТЕРИН-1-ОЛЬВЕКС) по ТУ 9398-042-44276594-2007
- Device Type (English)
- N/A
- Device Type (Russian)
- 204950
- Risk Class
- Class 2a
- OKPD Code
- 21.20.23.110
- Registry Key
- 68106.0
- Registration Number
- ФСР 2008/01913
- Registration Date
- December 28, 2022
- Manufacturer Name (English)
- OLVEX DIAGNOSTICS LLC
- Manufacturer Name (Russian)
- ООО "ОЛЬВЕКС ДИАГНОСТИКУМ"
- Country (English)
- Russia
- Country (Russian)
- Россия
- Legal Address (English)
- OLVEX DIAGNOSTICUM LLC, 10 Oktyabrskaya nab., bldg. 1, bldg. 1, St. Petersburg, 193091 Russia
- Legal Address (Russian)
- ООО "ОЛЬВЕКС ДИАГНОСТИКУМ", Россия, 193091, Санкт-Петербург, Октябрьская наб., д. 10, к. 1, стр. 1
- Manufacturing Address
- 199155, Россия, Санкт-Петербург, пер. Декабристов, д. 5/17, кв. 1
Access comprehensive regulatory information for Reagent kit for determining the concentration of total cholesterol in serum and plasma (CHOLESTEROL-1-OLVEX) as per TU 9398-042-44276594-2007 in the Russia medical device market through Pure Global AI's free database. This Class 2a medical device is registered under Roszdravnadzor registration number ФСР 2008/01913 and manufactured by OLVEX DIAGNOSTICS LLC. The device was registered on December 28, 2022.
This page provides complete registration details including device type, manufacturer information, country of origin (Russia), and regulatory compliance data from the official Russia Roszdravnadzor medical device database. Pure Global AI offers free access to Russia's complete medical device registry, helping global MedTech companies navigate Roszdravnadzor regulations efficiently.